Search hospitals > Wisconsin > Green Bay

Bellin Memorial Hospital

Claim this profile
Green Bay, Wisconsin 54301
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Leukemia
Conducts research for Lung Cancer
Conducts research for Lymphoma
84 reported clinical trials
3 medical researchers
Photo of Bellin Memorial Hospital in Green BayPhoto of Bellin Memorial Hospital in Green BayPhoto of Bellin Memorial Hospital in Green Bay

Summary

Bellin Memorial Hospital is a medical facility located in Green Bay, Wisconsin. This center is recognized for care of Cancer, Breast Cancer, Leukemia, Lung Cancer, Lymphoma and other specialties. Bellin Memorial Hospital is involved with conducting 84 clinical trials across 170 conditions. There are 3 research doctors associated with this hospital, such as Hassan I. Tahsildar, Kevin L. Mortara, and Adam L. Liss.

Area of expertise

1Cancer
Global Leader
Bellin Memorial Hospital has run 17 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Bellin Memorial Hospital has run 16 trials for Breast Cancer. Some of their research focus areas include:
ER positive
HER2 negative
PR positive

Top PIs

Clinical Trials running at Bellin Memorial Hospital

Non-Small Cell Lung Cancer
Lung Cancer
Breast Cancer
Prostate Cancer
Colorectal Cancer
Cancer
Squamous Cell Carcinoma
Prostate Adenocarcinoma
ALK Gene Rearrangement
Skin Cancer
Image of trial facility.

Immunotherapy + Chemotherapy

for Non-Small Cell Lung Cancer

This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Image of trial facility.

Crizotinib

for Non-Small Cell Lung Cancer

This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Image of trial facility.

Genetic Testing

for Early-Stage Lung Cancer

This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Bellin Memorial Hospital?
Bellin Memorial Hospital is a medical facility located in Green Bay, Wisconsin. This center is recognized for care of Cancer, Breast Cancer, Leukemia, Lung Cancer, Lymphoma and other specialties. Bellin Memorial Hospital is involved with conducting 84 clinical trials across 170 conditions. There are 3 research doctors associated with this hospital, such as Hassan I. Tahsildar, Kevin L. Mortara, and Adam L. Liss.